List view / Grid view
2 June 2015 | By Victoria White
Encouraging results have been announced from a Phase 1/2 trial of SCIB1, a DNA ImmunoBody being developed for the treatment of patients with melanoma...
2 June 2015 | By kdm communications
Syrris, a world leader in chemistry product innovation, has launched the Atlas Nanoparticle System for the automated synthesis of quantum dots...
2 June 2015 | By Victoria White
The Future of Anticoagulation Report highlights that urgent action is critical to lessening the potential impact of atrial fibrillation...
2 June 2015 | By Victoria White
The rheumatoid arthritis therapeutics market in the Asia-Pacific (APAC) region will expand in value from $5.6 billion in 2014 to an estimated $7 billion by 2021, at a moderate Compound Annual Growth Rate (CAGR) of 3.3%, according to business intelligence provider GBI Research.
2 June 2015 | By Victoria White
NICE has recommended aflibercept solution for injection and dexamethasone intravitreal implant as possible treatment options for diabetic macular oedema...
2 June 2015 | By Victoria White
Amgen and Roche are to collaborate on a study to evaluate talimogene laherparepvec in combination with atezolizumab in patients with cancer...
2 June 2015 | By Victoria White
Draft guidance issued by NICE on the drug olaparib do not recommend its use for maintenance treatment of ovarian, fallopian tube and peritoneal cancer...
From today, clinicians in England and Wales will be able to prescribe Roche's Gazyvaro for eligible patients with chronic lymphocytic leukaemia (CLL) on the NHS.
2 June 2015 | By Victoria White
The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), according to a new study...
1 June 2015 | By Victoria White
A new study compared the effectiveness of cabazitaxel alone versus cabazitaxel combined with carboplatin in patients with mCRPC...
1 June 2015 | By Victoria White
The EC has approved Lenvima in the treatment of adult patients with progressive, locally advanced or metastatic differentiated thyroid carcinoma...
1 June 2015 | By Victoria White
Results from a Phase III study show that Gazyvaro provided significant benefit for people with indolent non-Hodgkin’s lymphoma (NHL)...
1 June 2015 | By Victoria White
Results from a study of idelalisib in combination with ofatumumab in previously-treated patients with chronic lymphocytic leukaemia have been announced...
1 June 2015 | By Victoria White
AstraZeneca has announced preliminary efficacy and safety data for AZD9291 in the first-line treatment of EGFRm advanced non-small cell lung cancer (NSCLC)...
1 June 2015 | By Victoria White
The US Food and Drug Administration (FDA) has approved Pfizer’s RAPAMUNE (sirolimus) in the US for the treatment of lymphangioleiomyomatosis (LAM)...
